# ANAPTYSBIO INC (ANAB)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ANAB/

- Reporting holders: 4
- Reported value: $556.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $504.3K | 10,033 | 0.0% | 16 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $28.8K | 574 | 0.0% | 7 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $22.8K | 454 | 0.0% | 8 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $603 | 12 | 0.0% | 12 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $556.5K |
| Q2 2026 | 215 | $2.3B |
| Q1 2026 | 206 | $1.6B |
| Q4 2025 | 181 | $1.5B |
| Q3 2025 | 167 | $1.0B |
| Q2 2025 | 149 | $824.4M |
| Q1 2025 | 154 | $755.6M |
| Q4 2024 | 143 | $524.2M |
| Q3 2024 | 165 | $1.2B |
| Q2 2024 | 133 | $748.7M |
| Q1 2024 | 133 | $690.1M |
| Q4 2023 | 119 | $662.2M |